Advances in the Diagnosis and Management of Musculoskeletal Tumors

A Special Issue of Diagnostics (ISSN 2075-4418) belonging to the section "Pathology and Molecular Diagnostics".

Deadline for manuscript submissions: 30 November 2026 | Viewed by 2163

Editor


E-Mail Website
Guest Editor
Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu 514-8570, Japan
Interests: orthopedic oncology; soft tissue sarcoma; bone sarcoma; metastasis; limb salvage surgery
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The diagnosis and management of musculoskeletal tumors remain challenging due to the large number of histologies and variety of radiological findings. Over the past 50 years, new diagnostic devices have been developed and implemented, and physicians have continuously strived to improve the accuracy of diagnosis and the management of musculoskeletal tumors.

This Special Issue invites original papers and review articles that explore new techniques in diagnostic devices, surgery, and radiotherapy. Submissions on chemotherapy and immunotherapy aimed at improving survival in patients with musculoskeletal tumors, including metastatic bone tumors, are also encouraged.

Both basic and clinical research are welcome. I look forward to receiving your contributions.

Dr. Tomoki Nakamura
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bone tumors
  • soft tissue tumors
  • metastatic bone tumors
  • diagnosis
  • chemotherapy
  • immunotherapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

12 pages, 482 KB  
Article
Clinical Diagnosis and Treatment in Patients with Schwannoma at a Single Institute
by Tomoki Nakamura, Ryohei Adachi, Tomohito Hagi, Yumi Matsuyama, Hironori Date and Masahiro Hasegawa
Diagnostics 2026, 16(15), 2299; https://doi.org/10.3390/diagnostics16152299 - 23 Jul 2026
Viewed by 1570
Abstract
Background/Objectives: The aim of this study was to review the clinical course of schwannoma in 176 patients and elucidate the clinical outcome in a patient who received surgical treatment and one who did not. Methods: Between August 2006 and December 2021, [...] Read more.
Background/Objectives: The aim of this study was to review the clinical course of schwannoma in 176 patients and elucidate the clinical outcome in a patient who received surgical treatment and one who did not. Methods: Between August 2006 and December 2021, 176 patients with solitary and sporadic schwannomas were enrolled in our institution. There were 94 men and 82 women, with a mean age of 57 years. During follow-up, 76 patients received surgical treatment, and the remaining 100 did not. Results: The mean tumor size at initial presentation was 30 mm. The major tumor locations were the thigh, lower leg, upper arm, and forearm. The major nerves affected by the schwannoma were the intramuscular branch, sciatic nerve, and ulnar nerve. At least one symptom in addition to a palpable mass was observed in 133 patients (76%). The variables that indicated surgical treatment were tumor size at initial presentation, age, and any other existing symptoms. After surgery, pain-related symptoms including pain, irradiated pain and tenderness were resolved completely in 42 of 44 patients (95%) who had displayed them preoperatively. Neurological deficit was observed in 26 patients (34%). Among the 26 patients with neurological deficit, neurological sensory deficit was observed in 23 patients, and the remaining three had sensory and motor deficits. Multivariate analysis showed that patients with major nerve schwannoma, those with paresthesia preoperatively, and those who developed preoperative symptoms and had undergone surgery had a higher risk of the development of postoperative neurological deficit. Conclusions: Our findings should be considered while planning surgery and obtaining informed consent. Full article
(This article belongs to the Special Issue Advances in the Diagnosis and Management of Musculoskeletal Tumors)
Show Figures

Figure 1

Back to TopTop